Graham Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,813
Closed -$286K 1494
2025
Q3
$286K Sell
26,813
-115,846
-81% -$1.14M ﹤0.01% 883
2025
Q2
$1.38M Buy
+142,659
New +$1.47M 0.02% 479
2025
Q1
Sell
-36,105
Closed -$539K 1453
2024
Q4
$539K Sell
36,105
-64,781
-64% -$1.06M 0.01% 710
2024
Q3
$1.93M Buy
100,886
+83,032
+465% +$1.72M 0.03% 284
2024
Q2
$370K Buy
+17,854
New +$355K 0.01% 672

Other funds holding OGN

Graham Capital Management's OGN Position: Q4 2025 in Review

Graham Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 26,813 shares — an estimated $286K sold.

Graham Capital Management first reported a position in OGN in Q2 2024 and held it in 5 quarters. The position peaked at $1.93M in Q3 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Graham Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 26,813 Organon & Co shares in Q4 2025, an estimated $286K.
  • Graham Capital Management first reported a position in Organon & Co in Q2 2024 and held it in 5 quarters.
  • Graham Capital Management's Organon & Co position peaked at $1.93M in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.